KEAP1 and cancer: To confirm the KEAP1 interaction with 4-OI in cancer cells, 786-O cells were treated with the 4-OI-alk probe for 4 or 24 h, which demonstrated enrichment in KEAP1 upon CuAAC conjugation to biotin azide and subsequent streptavidin-based affinity pull-down (Fig. 4b).